MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Aberrant microRNA (miRNA) expression is a hallmark of cancer, with miRNAs playing crucial roles in tumor development and progression.
• MiR-7 is recognized as a tumor suppressor in various cancers, but its function and mechanism in human hepatocellular carcinoma (HCC) remain unclear.

Purpose of the Study:

• To investigate the role of miR-7 in human hepatocellular carcinoma (HCC) and elucidate its underlying molecular mechanisms.
• To identify direct target genes of miR-7 involved in cell cycle regulation in HCC.

Main Methods:

• Bioinformatic prediction, reporter assays, quantitative real-time PCR (qRT-PCR), and Western blot analysis were employed.
• Cell cycle analysis was performed upon miR-7 overexpression and CCNE1 manipulation.
• Expression analysis of miR-7 and CCNE1 in clinical HCC tissues and cell lines.

Main Results:

• Overexpression of miR-7 induced cell cycle arrest at the G1 to S transition in HCC cells.
• CCNE1 was identified as a direct target gene of miR-7, mediating G1/S transition.
• Silencing CCNE1 mimicked miR-7's effects, while CCNE1 overexpression reversed them.
• A reciprocal expression pattern between miR-7 and CCNE1 was observed in HCC tissues and cell lines.

Conclusions:

• MiR-7 exerts tumor-suppressive effects in hepatocarcinogenesis by inhibiting the oncogene CCNE1.
• MiR-7's regulation of CCNE1 impacts cell cycle progression in HCC.
• MiR-7 holds potential as a therapeutic agent for HCC.